ACHILLES THERAPEUTICS PL-ADR (ACHL)

US00449L1026 - ADR

0.8  -0.01 (-1.78%)

Premarket: 0.829 +0.03 (+3.62%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
75.25M77.88M64.20M33.73M13.78M
Research and Development
58.25M56.76M42.22M22.63M9.07M
Selling, General, and Administrative Expenses
17.01M21.12M21.97M11.10M4.70M
Operating Income
-75.25M-77.88M-64.20M-33.73M-13.78M
Interest Income/Expense
-1.00M3.80M2.50M100.00K400.00K
Other Income/Expense
7.08M3.52M630.00K430.00K-620.00K
Non Recurring Items
N/A-500.00KN/AN/AN/A
Income Before Taxes
-69.17M-71.07M-61.06M-33.20M-13.99M
Income Tax
491.00K110.00K40.00K0.000.00
Net Income
-69.67M-71.18M-61.10M-33.20M-13.99M
EBITDA
-70.54M-74.19M-60.91M-32.96M-13.48M
 
Per Share Data
EPS Diluted Total Ops
-1.72-1.79-2.10-0.81-0.34
Non GAAP EPS
-1.74-1.82-9.62N/AN/A
 
Statistics

All data in USD

Charts